Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 21Myelodysplastic Syndromes 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia 14Multiple Myeloma 12Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 11Hodgkin Disease 11Lymphoma, Non-Hodgkin 10Leukemia, Myeloid, Chronic-Phase 8Primary Myelofibrosis 7Neoplasms, Plasma Cell 7Myeloproliferative Disorders 7Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Leukemia, Myelomonocytic, Chronic 7Congenital Abnormalities 7Lymphoma, Follicular 6Leukemia, Myeloid, Accelerated Phase 6Hematologic Neoplasms 6Blast Crisis 6Sezary Syndrome 5Mycosis Fungoides 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Temozolomide 41Radiotherapy 15Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 10Bevacizumab 10Irinotecan 9Radiation 8Nivolumab 7Carmustine 7Specimen Handling 6Radiosurgery 6Carboplatin 6ribociclib 5O(6)-benzylguanine 5Imiquimod 5IL13-PE38 5Flucytosine 5Filgrastim 5Erlotinib Hydrochloride 5Cyclophosphamide 5Aminolevulinic Acid 5vandetanib 4sargramostim 4Topotecan 4Lomustine 4Imatinib Mesylate 4Etoposide 4Craniotomy 4vocimagene amiretrorepvec 3temsirolimus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Glioma × Tacrolimus × Clear all
NCT04521946 2024-10-26

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

M.D. Anderson Cancer Center

Phase 1 Withdrawn
CNS

Choroid Plexus Carcinoma, Brain Neoplasms, Ependymoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡